These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 6066044)
21. Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells. Sensi ML; Parenza M; Parmiani G J Natl Cancer Inst; 1983 Feb; 70(2):291-7. PubMed ID: 6571938 [TBL] [Abstract][Full Text] [Related]
22. The induction of lymphocytes with the capacity to render macrophages cytotoxic in an allogeneic murine system. De Weger RA; Pels E; Den Otter W Immunology; 1982 Nov; 47(3):541-50. PubMed ID: 6215342 [TBL] [Abstract][Full Text] [Related]
23. Some properties of histocompatibility isoantigens. Stetson CA Fed Proc; 1965; 24(5):1023. PubMed ID: 5838169 [No Abstract] [Full Text] [Related]
24. Quantitative studies of antigen expression in cultured murine lymphoma cells. I. Cell-surface antigens in "Asynchronous" cultures. Cikes M; Klein G J Natl Cancer Inst; 1972 Dec; 49(6):1599-606. PubMed ID: 4647845 [No Abstract] [Full Text] [Related]
25. Relationship between Fc (IgG) receptors and alloantigens on the surface of BALB/c B cell lymphoma lines. Kanellopoulos-Langevin C; Kim KJ; Sachs DH; Asofsky R J Immunol; 1979 Dec; 123(6):2651-7. PubMed ID: 501085 [No Abstract] [Full Text] [Related]
26. Demonstration of H-2 isoantigens and polyoma specific tumor antigens by measuring colony formation in vitro. Hellström I; Sjögren HO Exp Cell Res; 1965 Oct; 40(1):212-5. PubMed ID: 4284529 [No Abstract] [Full Text] [Related]
27. H 9/25 monoclonal antibody recognizes a new allospecificity of mouse lymphocyte subpopulations: strain and tissue distribution. Takei F; Galfrè G; Alderson T; Lennox ES; Milstein C Eur J Immunol; 1980 Apr; 10(4):241-6. PubMed ID: 7398756 [TBL] [Abstract][Full Text] [Related]
28. Biological effects of allogeneic effect factor on T lymphocytes: in vitro induction of cytotoxic T lymphocytes manifesting preferential lytic activity against H-2-identical tumor cells. Altman A; Bechtold TE; Cardenas JM; Katz DH Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3477-81. PubMed ID: 315066 [TBL] [Abstract][Full Text] [Related]
29. Characterization of antigens on murine tumor cells reacting with alloantisera against foreign H-2 specificities: analysis by absorption with purified murine leukemia virus and normal lymphoid cells of different H-2 haplotypes. Schirrmacher V; Marxen I; Robinson P Z Immunitatsforsch Immunobiol; 1978 Dec; 155(2):155-68. PubMed ID: 85374 [TBL] [Abstract][Full Text] [Related]
30. Foreign H-2-like alloantigens of syngeneic tumor cells can act as new "restriction" molecules for the associative recognition of non-H-2 or tumor-associated antigens by lymphoid effectors in the cytostasis assay. Festenstein H; de Giorgi L; Matossian-Rogers A Transplant Proc; 1981 Dec; 13(4):1877-9. PubMed ID: 7330973 [No Abstract] [Full Text] [Related]
31. In vitro studies of mammalian somatic cell variation. II. Isoimmune cytotoxicity with a cultured mouse lymphoma and selection of resistant variants. CANN HM; HERZENBERG LA J Exp Med; 1963 Feb; 117(2):267-84. PubMed ID: 14018309 [TBL] [Abstract][Full Text] [Related]
32. Allosensitization induced suppression of various murine tumors: role of non-H-2 antigens in antitumor immunity. Thakur VS; Seshadri M; Poduval TB; Shah DH; Sundaram K Indian J Exp Biol; 1990 Aug; 28(8):706-10. PubMed ID: 2253959 [TBL] [Abstract][Full Text] [Related]
33. Expression of Ly 1, Ly 2, Thy 1, and TL differentiation antigens on mouse T-cell tumors. Mathieson BJ; Campbell PS; Potter M; Asofsky R J Exp Med; 1978 Apr; 147(4):1267-79. PubMed ID: 306411 [TBL] [Abstract][Full Text] [Related]
34. Anti-thymocyte autoimmunity in BALB/C mice accompanying immunization to a syngeneic lymphoma. Baechtel FS; Prager MD J Immunol; 1977 Jan; 118(1):175-9. PubMed ID: 299754 [TBL] [Abstract][Full Text] [Related]
35. Resistance to syngeneic lymphoma cells as a result of immunization with chemically modified allogeneic lymphoma cells in mice. Gillette RW; Berringer DC; Wunderlich DA J Natl Cancer Inst; 1978 Jun; 60(6):1427-32. PubMed ID: 650705 [TBL] [Abstract][Full Text] [Related]
36. Comparison of the allospecific and viral-specific immune responses to irradiated versus formaldehyde-fixed allogeneic Moloney lymphoma cells in CBA mice. Lamon EW; Gatti RA; Kiessling R; Fenyö EM Cancer Res; 1975 Apr; 35(4):962-9. PubMed ID: 1090367 [TBL] [Abstract][Full Text] [Related]
37. Variation of antigenic characteristics between different mouse lymphomas induced by the Moloney virus. Klein G; Klein E; Haughton G J Natl Cancer Inst; 1966 Apr; 36(4):607-21. PubMed ID: 4286935 [No Abstract] [Full Text] [Related]
38. Hepatocyte-tumor cell interaction in vitro. I. Conditions for rosette formation and inhibition by anti-H-2 antibody. Schirrmacher V; Cheingsong-Popov R; Arnheiter H J Exp Med; 1980 Apr; 151(4):984-9. PubMed ID: 7373219 [TBL] [Abstract][Full Text] [Related]
39. Relationship between isoantigenicity and transplantation behaviour of tumor homografts. Möller E Bibl Haematol; 1965; 23():167-71. PubMed ID: 5885044 [No Abstract] [Full Text] [Related]
40. Serum-mediated protection of neoplastic cells from inhibition by lymphocytes immune to their tumor-specific antigens. Hellström I; Hellström KE; Evans CA; Heppner GH; Pierce GE; Yang JP Proc Natl Acad Sci U S A; 1969 Feb; 62(2):362-8. PubMed ID: 5256215 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]